Neurorehabilitation Devices Market Value Anticipated To Reach US$ 3,476.3 Million By 2027: Acumen Research and Consulting
February 05, 2021 11:02 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Neurorehabilitation Devices Market– Global Industry Analysis, Market Size,...
Brain Scientific Unveils New Initiative to Develop Brain E-Tattoo Device for the Brain Diagnostics Market
January 21, 2021 08:30 ET
|
Brain Scientific Inc.
Powered by A.I., Brain E-Tattoo Technology is Expected to Provide Continuous Monitoring for Uninterrupted Data Collection in Patients with Epilepsy, Alzheimer’s, Stroke, and More. NEW YORK, Jan. 21,...
Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight
January 05, 2021 09:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight DelveInsight predicts a favorable growth...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
December 28, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children
December 17, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has announced its next generation...
InvestorBrandNetwork Announces ‘Want Money Got Money’ Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco
December 16, 2020 08:30 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Dec. 16, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
December 15, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a...
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
December 15, 2020 07:55 ET
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Global Cancer Stem Cells Market to Boost with CAGR of 11.8% and Cross a Margin of $1,898.3 Million During the Covid-19 Outbreak – Exclusive Report [150 Pages] by Research Dive
December 08, 2020 09:05 ET
|
Research Dive
New York, USA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The cancer stem cells market is anticipated to grow rapidly in the Covid-19 outbreak due to usage of cancer stem cells for treating cancer. According...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
November 24, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...